We are live on ! Find out more
RDUS

Radius Health, Inc.

Delisted

RDUS was delisted on the 12th of August, 2022.

135 hedge funds and large institutions have $602M invested in Radius Health, Inc. in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more call options, than puts

Call options by funds: $3.77M | Put options by funds: $1.54M

31% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 16

3% more funds holding

Funds holding: 131135 (+4)

9% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 43

32% less capital invested

Capital invested by funds: $891M → $602M (-$289M)

Holders
135
Holders Change
+4
Holders Change %
+3.05%
% of All Funds
2.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
47
Reduced
43
Closed
16
Calls
$3.77M
Puts
$1.54M
Net Calls
+$2.23M
Net Calls Change
+$2.53M
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
76
Dupont Capital Management
Delaware
$320K -$52.5K -3,644 -12%
AIG
77
American International Group
New York
$318K -$8.78K -609 -2%
State Board of Administration of Florida Retirement System
78
State Board of Administration of Florida Retirement System
Florida
$314K
Cambridge Investment Research Advisors
79
Cambridge Investment Research Advisors
Iowa
$306K
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$305K -$20.7K -1,437 -6%
VEA
81
Virtus ETF Advisers
New York
$302K -$32.3K -2,240 -8%
Bank of America
82
Bank of America
North Carolina
$291K -$22.2K -1,541 -6%
SAM
83
Shell Asset Management
Netherlands
$287K -$14.3K -990 -4%
Invesco
84
Invesco
Georgia
$275K +$50.4K +3,495 +19%
IA
85
IndexIQ Advisors
New York
$267K +$31.1K +2,159 +11%
Acadian Asset Management
86
Acadian Asset Management
Massachusetts
$267K +$287K +19,929 +1,252%
SG Americas Securities
87
SG Americas Securities
New York
$265K +$308K +21,357 New
Vontobel Holding
88
Vontobel Holding
Switzerland
$248K
ZCM
89
Zebra Capital Management
Connecticut
$233K +$270K +18,742 New
Jane Street
90
Jane Street
New York
$220K +$59.1K +4,099 +30%
TI
91
Trexquant Investment
Connecticut
$208K +$241K +16,722 New
ProShare Advisors
92
ProShare Advisors
Maryland
$200K -$65.4K -4,536 -22%
DekaBank Deutsche Girozentrale
93
DekaBank Deutsche Girozentrale
Germany
$197K
EAM
94
Erste Asset Management
Austria
$195K
Handelsbanken Fonder
95
Handelsbanken Fonder
Sweden
$186K
SM
96
SG3 Management
Puerto Rico
$186K +$216K +15,000 New
DCM
97
DAFNA Capital Management
California
$180K
BFM
98
Boothbay Fund Management
New York
$176K -$36.2K -2,513 -15%
Wolverine Trading
99
Wolverine Trading
Illinois
$172K +$191K +13,280 New
Millennium Management
100
Millennium Management
New York
$170K -$1.3M -89,978 -87%

RDUS Hedge Fund Activity: Q3 2021 in Review

135 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q3 2021, worth a combined $602M — down 32% from $891M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RDUS positions and 16 closed out — a net gain of 5 holders — while 47 added to existing stakes and 43 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $39.3M. The largest seller was Artisan Partners, exiting entirely with an estimated $29.4M sold.

  • 135 institutional investors held Radius Health, Inc. (RDUS) as of Q3 2021, up from 131 in Q2 2021.
  • Funds reported $602M of Radius Health, Inc. stock for Q3 2021, down 32% quarter-over-quarter.
  • 21 funds opened new Radius Health, Inc. positions in Q3 2021 and 16 closed out, a net change of +5 holders.
  • The largest Radius Health, Inc. buyer in Q3 2021 was Rubric Capital Management (New York), an estimated $39.3M added.
  • The largest Radius Health, Inc. seller in Q3 2021 was Artisan Partners, an estimated $29.4M sold.

Based on aggregated 13F filings for Q3 2021.